VBI Vaccines (VBIV) Q2 2023 Earnings

14AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-3.22
-2.17
-1.12
-0.07

Details

Expected EPS
-2.16
Actual EPS
-2.17
Surprise EPS
-0.01
Surprise Percent
+0.46%

Description

VBI Vaccines (VBIV) has reported earnings of -2.17 per share for Q2 2023.

0 Comments

Share your thoughts